AI Drives Major Advancements and Investments Across Healthcare and Biotechnology

Key Intelligence

• ■Significant capital is flowing into AI in healthcare, highlighted by a nearly $2 billion cross-sector collaboration (Biohub, Google, Meta, US government) for foundational biology data and Alphabet's Isomorphic Labs seeking funding at a $40 billion valuation for AI drug discovery.
• ■AI is rapidly advancing drug and antibody discovery, with companies like DaltonTx and Danaher launching autonomous AI labs and new models for novel antibody development and protein design.
• ■Clinical applications of AI are expanding, including 'AI-powered prescriptions,' enhanced CT scan interpretation with explainability features, AI tools for physical therapy, and clinical decision support systems.
• ■Efforts are underway to ensure safe and transparent AI integration, with initiatives focused on 'human-centered' AI and studies showing how safety prompts can improve AI models' clinical choices.